The global MRD Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the MRD Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global MRD Testing market. MRD Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of MRD Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the MRD Testing market.
Minimal residual disease (MRD) testing is the future of diagnostics and monitoring for cancer, according to some experts. Not only can MRD determine the depth of response to a treatment, but it can also be used to determine treatment strategies.
Key Features:
The report on MRD Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the MRD Testing market. It may include historical data, market segmentation by Type (e.g., Flow Cytometry, Polymerase Chain Reaction (PCR)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the MRD Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the MRD Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the MRD Testing industry. This include advancements in MRD Testing technology, MRD Testing new entrants, MRD Testing new investment, and other innovations that are shaping the future of MRD Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the MRD Testing market. It includes factors influencing customer ' purchasing decisions, preferences for MRD Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the MRD Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting MRD Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the MRD Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the MRD Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the MRD Testing market.
Market Segmentation:
MRD Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Other Technologies
Segmentation by application
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions
Other End Users
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ICON
ArcherDX
Arup Laboratories
ASURAGEN INC
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
Laboratory Corporation of America Holdings
Inivata Ltd
Natera, Inc
NeoGenomics Laboratories, Inc
Opko Health
Quest Diagnostics Incorporated
Sysmex Corporation
Adaptive Biotechnologies Corporation
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global MRD Testing Market Size 2019-2030
2.1.2 MRD Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 MRD Testing Segment by Type
2.2.1 Flow Cytometry
2.2.2 Polymerase Chain Reaction (PCR)
2.2.3 Next-Generation Sequencing (NGS)
2.2.4 Other Technologies
2.3 MRD Testing Market Size by Type
2.3.1 MRD Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global MRD Testing Market Size Market Share by Type (2019-2024)
2.4 MRD Testing Segment by Application
2.4.1 Specialty Clinics and Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Research Institutions
2.4.4 Other End Users
2.5 MRD Testing Market Size by Application
2.5.1 MRD Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global MRD Testing Market Size Market Share by Application (2019-2024)
3 MRD Testing Market Size by Player
3.1 MRD Testing Market Size Market Share by Players
3.1.1 Global MRD Testing Revenue by Players (2019-2024)
3.1.2 Global MRD Testing Revenue Market Share by Players (2019-2024)
3.2 Global MRD Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRD Testing by Regions
4.1 MRD Testing Market Size by Regions (2019-2024)
4.2 Americas MRD Testing Market Size Growth (2019-2024)
4.3 APAC MRD Testing Market Size Growth (2019-2024)
4.4 Europe MRD Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa MRD Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas MRD Testing Market Size by Country (2019-2024)
5.2 Americas MRD Testing Market Size by Type (2019-2024)
5.3 Americas MRD Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC MRD Testing Market Size by Region (2019-2024)
6.2 APAC MRD Testing Market Size by Type (2019-2024)
6.3 APAC MRD Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe MRD Testing by Country (2019-2024)
7.2 Europe MRD Testing Market Size by Type (2019-2024)
7.3 Europe MRD Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa MRD Testing by Region (2019-2024)
8.2 Middle East & Africa MRD Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa MRD Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global MRD Testing Market Forecast
10.1 Global MRD Testing Forecast by Regions (2025-2030)
10.1.1 Global MRD Testing Forecast by Regions (2025-2030)
10.1.2 Americas MRD Testing Forecast
10.1.3 APAC MRD Testing Forecast
10.1.4 Europe MRD Testing Forecast
10.1.5 Middle East & Africa MRD Testing Forecast
10.2 Americas MRD Testing Forecast by Country (2025-2030)
10.2.1 United States MRD Testing Market Forecast
10.2.2 Canada MRD Testing Market Forecast
10.2.3 Mexico MRD Testing Market Forecast
10.2.4 Brazil MRD Testing Market Forecast
10.3 APAC MRD Testing Forecast by Region (2025-2030)
10.3.1 China MRD Testing Market Forecast
10.3.2 Japan MRD Testing Market Forecast
10.3.3 Korea MRD Testing Market Forecast
10.3.4 Southeast Asia MRD Testing Market Forecast
10.3.5 India MRD Testing Market Forecast
10.3.6 Australia MRD Testing Market Forecast
10.4 Europe MRD Testing Forecast by Country (2025-2030)
10.4.1 Germany MRD Testing Market Forecast
10.4.2 France MRD Testing Market Forecast
10.4.3 UK MRD Testing Market Forecast
10.4.4 Italy MRD Testing Market Forecast
10.4.5 Russia MRD Testing Market Forecast
10.5 Middle East & Africa MRD Testing Forecast by Region (2025-2030)
10.5.1 Egypt MRD Testing Market Forecast
10.5.2 South Africa MRD Testing Market Forecast
10.5.3 Israel MRD Testing Market Forecast
10.5.4 Turkey MRD Testing Market Forecast
10.5.5 GCC Countries MRD Testing Market Forecast
10.6 Global MRD Testing Forecast by Type (2025-2030)
10.7 Global MRD Testing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 ICON
11.1.1 ICON Company Information
11.1.2 ICON MRD Testing Product Offered
11.1.3 ICON MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 ICON Main Business Overview
11.1.5 ICON Latest Developments
11.2 ArcherDX
11.2.1 ArcherDX Company Information
11.2.2 ArcherDX MRD Testing Product Offered
11.2.3 ArcherDX MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 ArcherDX Main Business Overview
11.2.5 ArcherDX Latest Developments
11.3 Arup Laboratories
11.3.1 Arup Laboratories Company Information
11.3.2 Arup Laboratories MRD Testing Product Offered
11.3.3 Arup Laboratories MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arup Laboratories Main Business Overview
11.3.5 Arup Laboratories Latest Developments
11.4 ASURAGEN INC
11.4.1 ASURAGEN INC Company Information
11.4.2 ASURAGEN INC MRD Testing Product Offered
11.4.3 ASURAGEN INC MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ASURAGEN INC Main Business Overview
11.4.5 ASURAGEN INC Latest Developments
11.5 Cergentis B.V.
11.5.1 Cergentis B.V. Company Information
11.5.2 Cergentis B.V. MRD Testing Product Offered
11.5.3 Cergentis B.V. MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cergentis B.V. Main Business Overview
11.5.5 Cergentis B.V. Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories MRD Testing Product Offered
11.6.3 Bio-Rad Laboratories MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
11.7 Mission Bio
11.7.1 Mission Bio Company Information
11.7.2 Mission Bio MRD Testing Product Offered
11.7.3 Mission Bio MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Mission Bio Main Business Overview
11.7.5 Mission Bio Latest Developments
11.8 Guardant Health
11.8.1 Guardant Health Company Information
11.8.2 Guardant Health MRD Testing Product Offered
11.8.3 Guardant Health MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Guardant Health Main Business Overview
11.8.5 Guardant Health Latest Developments
11.9 Invivoscribe
11.9.1 Invivoscribe Company Information
11.9.2 Invivoscribe MRD Testing Product Offered
11.9.3 Invivoscribe MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Invivoscribe Main Business Overview
11.9.5 Invivoscribe Latest Developments
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Information
11.10.2 Laboratory Corporation of America Holdings MRD Testing Product Offered
11.10.3 Laboratory Corporation of America Holdings MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Laboratory Corporation of America Holdings Main Business Overview
11.10.5 Laboratory Corporation of America Holdings Latest Developments
11.11 Inivata Ltd
11.11.1 Inivata Ltd Company Information
11.11.2 Inivata Ltd MRD Testing Product Offered
11.11.3 Inivata Ltd MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Inivata Ltd Main Business Overview
11.11.5 Inivata Ltd Latest Developments
11.12 Natera, Inc
11.12.1 Natera, Inc Company Information
11.12.2 Natera, Inc MRD Testing Product Offered
11.12.3 Natera, Inc MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Natera, Inc Main Business Overview
11.12.5 Natera, Inc Latest Developments
11.13 NeoGenomics Laboratories, Inc
11.13.1 NeoGenomics Laboratories, Inc Company Information
11.13.2 NeoGenomics Laboratories, Inc MRD Testing Product Offered
11.13.3 NeoGenomics Laboratories, Inc MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 NeoGenomics Laboratories, Inc Main Business Overview
11.13.5 NeoGenomics Laboratories, Inc Latest Developments
11.14 Opko Health
11.14.1 Opko Health Company Information
11.14.2 Opko Health MRD Testing Product Offered
11.14.3 Opko Health MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Opko Health Main Business Overview
11.14.5 Opko Health Latest Developments
11.15 Quest Diagnostics Incorporated
11.15.1 Quest Diagnostics Incorporated Company Information
11.15.2 Quest Diagnostics Incorporated MRD Testing Product Offered
11.15.3 Quest Diagnostics Incorporated MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Quest Diagnostics Incorporated Main Business Overview
11.15.5 Quest Diagnostics Incorporated Latest Developments
11.16 Sysmex Corporation
11.16.1 Sysmex Corporation Company Information
11.16.2 Sysmex Corporation MRD Testing Product Offered
11.16.3 Sysmex Corporation MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Sysmex Corporation Main Business Overview
11.16.5 Sysmex Corporation Latest Developments
11.17 Adaptive Biotechnologies Corporation
11.17.1 Adaptive Biotechnologies Corporation Company Information
11.17.2 Adaptive Biotechnologies Corporation MRD Testing Product Offered
11.17.3 Adaptive Biotechnologies Corporation MRD Testing Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Adaptive Biotechnologies Corporation Main Business Overview
11.17.5 Adaptive Biotechnologies Corporation Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
